Kite Pharma has initiated a global Phase 3 trial to test the CAR T-cell therapy anito-cel in relapsed or refractory multiple myeloma.| Rare Cancer News
Margarida Maia is a science writer for Myeloma Research News with a PhD in biomedical sciences. She covers the latest news and information on a variety of myeloma topics.| Rare Cancer News